IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DIANE EKLUND

Allopathic & Osteopathic Physicians Pathology Clinical Pathology

NPI
1376612317
CMS profile
1142975
Location
TUCSON, AZ

General Payments · PY2020–2024

$258,828.82

  • Reported across 164 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$65,021.35

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Clinical Pathology AZ All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $65,021.35 39

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $65,021.35 39

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $20,988.84 12
PY2021 $38,673.39 23
PY2022 $92,106.84 54
PY2023 $42,038.40 36
PY2024 $65,021.35 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $94.80 01/03/2024 Consulting Fee Undisputed 01/23/2026 1137538493 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 01/08/2024 Consulting Fee Undisputed 01/23/2026 1137538496 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 01/08/2024 Consulting Fee Undisputed 01/23/2026 1137538500 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137538504 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137538508 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 01/26/2024 Consulting Fee Undisputed 01/23/2026 1137538512 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 01/26/2024 Consulting Fee Undisputed 01/23/2026 1137538516 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 02/02/2024 Consulting Fee Undisputed 01/23/2026 1137538520 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137538523 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137538527 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137538531 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137538535 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 03/18/2024 Consulting Fee Undisputed 01/23/2026 1137538539 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137538542 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137538546 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137538550 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137538554 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 05/08/2024 Consulting Fee Undisputed 01/23/2026 1137538558 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137538562 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137538566 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 05/15/2024 Consulting Fee Undisputed 01/23/2026 1137538569 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137538573 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137538577 CMS
Takeda Pharmaceuticals U.S.A., Inc. $554.93 06/19/2024 Consulting Fee Undisputed 01/23/2026 1137538581 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137538585 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137538589 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137538593 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137538597 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137538601 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137538605 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,109.86 09/16/2024 Consulting Fee Undisputed 01/23/2026 1137538609 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 10/02/2024 Consulting Fee Undisputed 01/23/2026 1137538612 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137538616 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137538620 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137538624 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137538628 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137538631 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137538635 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,219.71 12/16/2024 Consulting Fee Undisputed 01/23/2026 1137538639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.